ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Stomach Cancer
Neoplasm Metastasis
Ovarian Cancer
Adenocarcinoma

Pancreatic Cancer trials near San Antonio, TX, USA:

Locations recently updated

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
G12D Mutated KRAS
Drug: VS-7375
Drug: cetuximab

Phase 2

Verastem

San Antonio, Texas, United States and 10 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

San Antonio, Texas, United States and 108 other locations

and clinical activity of AB680 in combination with zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Active, not recruiting
Advanced Pancreatic Cancer
Drug: Zimberelimab
Drug: Gemcitabine

Phase 1

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States and 15 other locations

(an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/2 inhibitor) in subjects with newly diagnosed and surgically resectable pancreatic...

Active, not recruiting
Pancreatic Cancer
Drug: Tislelizumab
Drug: SX-682

Phase 2

Lei Zheng

San Antonio, Texas, United States and 1 other location

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: mGnP
Drug: GnP

Phase 3

Immuneering Corporation

San Antonio, Texas, United States and 18 other locations

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...

Enrolling
Pancreatic Adenocarcinoma
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C

Phase 1, Phase 2

Astellas
Astellas

San Antonio, Texas, United States of America and 11 other locations

antitumor activity of RMC-5127 as a monotherapy and in combination with either daraxonrasib or cetuximab in adults with KRAS G12V-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: cetuximab
Drug: daraxonrasib

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 4 other locations

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 16 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutation...

Enrolling
PDAC - Pancreatic Ductal Adenocarcinoma
Advanced Solid Tumors
Drug: Pembrolizumab
Drug: Pemetrexed + Cisplatin /Carboplatin

Phase 1

Alterome Therapeutics, Inc.

San Antonio, Texas, United States and 11 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 20 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems